PPT-Phase 2 Trial Evaluating the Effect of Dexpramipexole on Eosinophil Biomarkers and Lung

Author : thomas | Published Date : 2022-06-11

Professor Salman Siddiqui Clinical Professor of Airways Disease University of Leicester UK Conflict of interest disclosure X I have the following real or perceived

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Phase 2 Trial Evaluating the Effect of D..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Phase 2 Trial Evaluating the Effect of Dexpramipexole on Eosinophil Biomarkers and Lung: Transcript

Professor Salman Siddiqui Clinical Professor of Airways Disease University of Leicester UK Conflict of interest disclosure X I have the following real or perceived conflicts of interest that relate to this presentation. Lung Function in Obstructive/Restrictive Disease. VC. VC. VC. TLC. VT. RV. VOLUME. (litres). Normal. COPD. VT. ERV. RV. 1. 2. 3. 4. 5. 6. 7. 8. 9. TLC. Restricted. VT. ERV. RV. TLC. Restriction Normal Obstruction. I. schemic . C. onditioning for Intracranial . A. thero. S. clerotic. . S. tr. O. ke. PICASSO TRIAL. Marc Chimowitz (MUSC). David C Hess (GRU). Renee Martin (MUSC). David . Liebeskind. (UCLA) Imaging. Sidima Sonqishe. Cardiothoracic. Registrar . II. University of Pretoria. The Importance:. To make a decision whether patient can tolerate surgery . To predict the occurrence of post operative respiratory complications and Mortality.. Expanding the Horizons. Basics of Biomarkers in RA. Biomarkers in ACR/EULAR RA Criteria. Discordance of Common RA Biomarkers. RA Practice Performance Project (RAPP). Framing the Discussion. Using ACPA Testing to Diagnose RA. Sidima Sonqishe. Cardiothoracic. Registrar . II. University of Pretoria. The Importance:. To make a decision whether patient can tolerate surgery . To predict the occurrence of post operative respiratory complications and Mortality.. Methods in Clinical Cancer Research. February 12, 2015. Effective incorporation of . biomarkers into phase II trials. There are many roles for biomarkers in Phase II trial designs.. Examples of biomarkers with pivotal role in development of new therapies. Project 1 – . Chris Amos. and James McKay. Project 2 – . Paul Brennan. and Mattias Johansson. Project 3 – . Rayjean Hung. Administrative Core – Chris Amos and Rayjean Hung. Biostatistics Core – . of Lung Cancer . Wendi S Lee, MSN, RN, NP-C. Anne S Tsao, MD. Disclosure for . Ms. Lee. Consulting Agreement. Pfizer Inc. Disclosures for Dr Tsao. Advisory Committee. Ariad Pharmaceuticals Inc, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals Inc, Bristol-Myers Squibb Company, EMD Serono Inc, Genentech, Huron, Lilly, Merck, Novartis, Roche Laboratories Inc, Seattle Genetics, SELLAS Life Sciences, Takeda Oncology. Brian A. . Ference. MD, . MPhil. , . MSc. , John J. P. Kastelein MD, PhD, . Kausik. K. Ray MD, . MPhil. , Henry N. Ginsberg MD, M. John Chapman PhD, . DSc. , Chris J. Packard . DSc. , Ulrich . Laufs. DOI:10.1183/09031936.94.07040743 the eosinophil leucocyte (Part II) * Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part II). C.Kroegel, J.A. Warner, J.-C. Virchow Jr, H. Ma Rama Vancheeswaran , FRCP, MSc . Immunol. , PhD. Royal Free NHS Foundation Trust. Learning objectives. Different types of lung function tests. Three major categories of diffuse lung disease. Understand the various subdivisions of the lung volume. Outline. Review of a phase I trial. What is a phase II trial?. Phase II trial process. Standard trial designs. Innovative trial designs. Phase II trial examples. Guess that trial. Phase II thalidomide study. Brad Rechtzigel Kohei Osterloth. "The gold standard for evaluating a new intervention" . -Allen Hackshaw. Main topics. What is Phase III?. What are the objectives?. What are the outcomes? . How large should the sample sizes be ?. LO: To use and understand the notation used for functions.. 3, 5, 7, 8 ….. Functions. 11, 15, 19, 21. 3. 11. We sometimes use a function machine to illustrate how functions behave ..

Download Document

Here is the link to download the presentation.
"Phase 2 Trial Evaluating the Effect of Dexpramipexole on Eosinophil Biomarkers and Lung"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.